View of Proposal of House Dust Mite Sublingual Immunotherapy Compared with Subcutaneous Immunotherapy for Treating Allergic Rhinitis with and without Asthma in the COVID-19 Pandemic

Return to Article Details Proposal of House Dust Mite Sublingual Immunotherapy Compared with Subcutaneous Immunotherapy for Treating Allergic Rhinitis with and without Asthma in the COVID-19 Pandemic Download Download PDF